Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The LEAP-SE study will be conducted to validate the utility of EEG biomarkers as an aid to antidepressant treatment selection in adults with MDD.
Epistemonikos ID: 3ef2d1b3550c6fb6bdf671b77d60d0aa1bd3d0be
First added on: May 07, 2024